TipRanks
Kintor Pharmaceutical Ltd (HK:9939)
:9939
Hong Kong Market
9939
Kintor Pharmaceutical Ltd
RESEARCH TOOLSreports
Want to see HK:9939 full AI Analyst Report?

Kintor Pharmaceutical Ltd (9939) Ratios

3 Followers

Kintor Pharmaceutical Ltd Ratios

HK:9939's free cash flow for Q2 2026 was ¥0.43. For the 2026 fiscal year, HK:9939's free cash flow was decreased by ¥ and operating cash flow was ¥-1.57. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.26 0.43 1.03 2.10 4.74
Quick Ratio
 0.20 0.34 1.02 2.10 2.84
Cash Ratio
 0.17 0.27 0.88 1.98 2.72
Solvency Ratio
 -0.72 -1.06 -0.62 -2.55 -1.68
Operating Cash Flow Ratio
 -0.82 -1.30 -1.19 -1.72 >-0.01
Short-Term Operating Cash Flow Coverage
 -1.12 -1.95 -1.78 -3.41 >-0.01
Net Current Asset Value
¥ -161.39M¥ -103.01M¥ -49.32M¥ 61.44M¥ 947.92M
Leverage Ratios
Debt-to-Assets Ratio
 0.42 0.25 0.26 0.29 0.14
Debt-to-Equity Ratio
 1.22 0.47 0.45 0.55 0.19
Debt-to-Capital Ratio
 0.55 0.32 0.31 0.36 0.16
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.06 0.23 0.11
Financial Leverage Ratio
 2.92 1.87 1.75 1.90 1.37
Debt Service Coverage Ratio
 -1.12 -1.62 -1.06 -8.49 -8.94
Interest Coverage Ratio
 -53.62 -52.00 -15.58 -109.31 -115.37
Debt to Market Cap
 0.19 0.11 0.34 0.39 0.08
Interest Debt Per Share
 0.28 0.20 0.33 0.61 0.78
Net Debt to EBITDA
 -0.64 -0.37 0.11 0.18 0.61
Profitability Margins
Gross Profit Margin
12.57%24.60%-94.60%0.00%0.00%
EBIT Margin
-254.95%-527.63%-2919.94%0.00%0.00%
EBITDA Margin
-205.20%-430.37%-2567.40%0.00%0.00%
Operating Profit Margin
-256.09%-611.29%-2891.36%0.00%0.00%
Pretax Profit Margin
-251.55%-621.01%-3105.48%0.00%0.00%
Net Profit Margin
-244.44%-612.29%-3105.84%0.00%0.00%
Continuous Operations Profit Margin
-249.12%-612.29%-3105.84%0.00%0.00%
Net Income Per EBT
97.17%98.59%100.01%99.25%100.11%
EBT Per EBIT
98.23%101.59%107.41%100.91%100.93%
Return on Assets (ROA)
-59.47%-58.69%-30.15%-122.04%-46.44%
Return on Equity (ROE)
-129.93%-109.54%-52.81%-231.56%-63.83%
Return on Capital Employed (ROCE)
-146.09%-93.65%-41.49%-164.35%-54.38%
Return on Invested Capital (ROIC)
-71.63%-66.83%-31.33%-137.83%-51.32%
Return on Tangible Assets
-84.98%-85.64%-42.41%-147.28%-53.42%
Earnings Yield
-25.43%-25.27%-39.57%-166.38%-29.14%
Efficiency Ratios
Receivables Turnover
 27.11 8.32 0.30 0.00 0.00
Payables Turnover
 2.13 0.77 0.25 0.99 0.27
Inventory Turnover
 6.16 2.04 4.39 0.00 0.04
Fixed Asset Turnover
 0.52 0.21 0.03 0.00 0.00
Asset Turnover
 0.24 0.10 <0.01 0.00 0.00
Working Capital Turnover Ratio
 -0.75 -0.97 0.04 0.00 0.00
Cash Conversion Cycle
 -98.69 -252.93 -178.40 -368.54 8.96K
Days of Sales Outstanding
 13.46 43.89 1.22K 0.00 0.00
Days of Inventory Outstanding
 59.23 179.18 83.09 0.00 10.30K
Days of Payables Outstanding
 171.38 475.99 1.48K 368.54 1.34K
Operating Cycle
 72.69 223.06 1.30K 0.00 10.30K
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.30 -0.37 -0.46 -0.90 >-0.01
Free Cash Flow Per Share
 -0.20 -0.37 -0.47 -0.91 >-0.01
CapEx Per Share
 0.10 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.67 1.00 1.01 1.01 1.03
Dividend Paid and CapEx Coverage Ratio
 -2.99 -228.76 -118.50 -142.34 -34.99
Capital Expenditure Coverage Ratio
 -2.99 -228.76 -118.50 -142.34 -34.99
Operating Cash Flow Coverage Ratio
 -1.12 -1.91 -1.50 -1.53 >-0.01
Operating Cash Flow to Sales Ratio
 -1.93 -5.06 -39.82 0.00 0.00
Free Cash Flow Yield
-14.07%-20.97%-51.16%-61.21%-0.03%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.69 -4.00 -2.53 -0.60 -3.43
Price-to-Sales (P/S) Ratio
 9.15 24.23 78.48 0.00 0.00
Price-to-Book (P/B) Ratio
 6.84 4.33 1.33 1.39 2.19
Price-to-Free Cash Flow (P/FCF) Ratio
 -7.12 -4.77 -1.95 -1.63 -3.31K
Price-to-Operating Cash Flow Ratio
 -4.98 -4.79 -1.97 -1.65 -3.41K
Price-to-Earnings Growth (PEG) Ratio
 0.96 -0.18 0.03 0.25 -0.48
Price-to-Fair Value
 6.84 4.33 1.33 1.39 2.19
Enterprise Value Multiple
 -5.10 -6.00 -2.94 -0.42 -2.82
Enterprise Value
 810.39M 843.67M 377.99M 446.02M 2.70B
EV to EBITDA
 -5.09 -6.00 -2.94 -0.42 -2.82
EV to Sales
 10.45 25.81 75.60 0.00 0.00
EV to Free Cash Flow
 -8.13 -5.08 -1.88 -1.14 -2.73K
EV to Operating Cash Flow
 -5.41 -5.10 -1.90 -1.15 -2.81K
Tangible Book Value Per Share
 0.22 0.17 0.34 0.72 3.26
Shareholders’ Equity Per Share
 0.22 0.41 0.68 1.07 3.97
Tax and Other Ratios
Effective Tax Rate
 0.03 -0.01 >-0.01 <0.01 >-0.01
Revenue Per Share
 0.16 0.07 0.01 0.00 0.00
Net Income Per Share
 -0.38 -0.44 -0.36 -2.47 -2.53
Tax Burden
 0.97 0.99 1.00 0.99 1.00
Interest Burden
 0.99 1.18 1.06 1.00 0.98
Research & Development to Revenue
 0.65 2.67 15.63 0.00 0.00
SG&A to Revenue
 2.03 1.83 17.68 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 -1.85 0.00 0.00
Income Quality
 0.79 0.85 1.28 0.36 1.01
Currency in CNY